1 Min Read
Nov 2 (Reuters) - Sage Therapeutics Inc
* Sage Therapeutics announces third quarter 2017 financial results and provides pipeline update
* Qtrly loss per share $1.97 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.